问HN：个性化mRNA癌症疫苗，当前的研发进展有多真实？
我发现了一个开源工作流程，用于设计个性化的mRNA癌症疫苗：
https://philfung.github.io/openvaxx/
还有一个关于一位男士与研究人员合作为他的狗创建个性化癌症疫苗的最新故事：
https://medicalxpress.com/news/2026-03-ai-cancer-vaccine-dog-oncologist.html
这让我开始思考目前在人类个性化mRNA医学领域的技术、研究和创业环境。
有没有在这个领域或相关领域工作的HN人士？我特别感兴趣的是：
- 目前在主要机构之外，这个管道的真实情况如何
- 哪些部分变得更便宜或更易获取
- 管道的哪些部分正在被软件和可能的新AI模型所取代
- 实际的瓶颈在哪里：测序、靶点选择、生产、质量控制、监管，还是其他方面
- 是否有人在围绕更个性化的mRNA疗法构建工具、基础设施或创业公司
查看原文
I came across this open-source workflow for designing personalized mRNA cancer vaccines:<p>https://philfung.github.io/openvaxx/<p>And this recent story about a man who worked with researchers to create a personalized cancer vaccine for his dog:<p>https://medicalxpress.com/news/2026-03-ai-cancer-vaccine-dog-oncologist.html<p>It got me wondering what the current technology, research, and startup landscape looks like for personalized mRNA medicine in humans.<p>Are any HN people working in this space, or close to it? I’m especially curious about:
- how real the pipeline is today outside major institutions
- which parts are getting cheaper or more accessible
- which parts of the pipeline is being taken over by software and possibly new AI models
- where the real bottlenecks are: sequencing, target selection, manufacturing, QC, regulation, or something else
- whether anyone is building tools, infrastructure, or startups around more individualized mRNA therapies